Trials / Conditions / Severe Acute Respiratory Syndrome (SARS) Pneumonia

Severe Acute Respiratory Syndrome (SARS) Pneumonia

10 registered clinical trials studyying Severe Acute Respiratory Syndrome (SARS) Pneumonia.

Status	Trial	Sponsor	Phase
Unknown	Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19 NCT04299152	Throne Biotechnologies Inc.	Phase 2
Completed	Practice Variation on Antithrombotics in COVID-19 NCT04998799	NMC Specialty Hospital	—
Completed	Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care NCT04681001	Marinomed Biotech AG	N/A
Completed	GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia NCT04569877	University of Giessen	Phase 2
Unknown	Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-8 NCT04480333	Biomed Industries, Inc.	Phase 1
Terminated	Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 NCT04366791	Emory University	Phase 1 / Phase 2
Completed	Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 NCT04343729	Fundação de Medicina Tropical Dr. Heitor Vieira Dourado	Phase 2
Completed	Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection NCT04342650	Fundação de Medicina Tropical Dr. Heitor Vieira Dourado	Phase 2
Completed	Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome NCT04323592	University of Trieste	—
Completed	Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 NCT04323527	Fundação de Medicina Tropical Dr. Heitor Vieira Dourado	Phase 2